BDR Pharmaceuticals announces license agreement with DRDO to manufacture 2-DG drug in India
Last month, the Drugs Controller General of India (DCGI) had approved the oral medication for emergency usage as adjuvant therapy…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.